TPXimpact Holdings Valuation

Q: What is the Fair Price of 9L7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

9L7 (€0.36) is trading below our estimate of [[fair value]] (€1.44)

Is 9L7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 9L7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 9L7 (€0.36) is trading below our estimate of fair value (€1.44)

Significantly Below Fair Value: 9L7 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 9L7?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 9L7. This is calculated by dividing 9L7's market cap by their current preferred multiple.
What is 9L7's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	UK£31.06m

9L7 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.5x
Enterprise Value/EBITDA	37.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 9L7's PS Ratio compare to its peers?

The above table shows the PS ratio for 9L7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1x
KSC KPS	0.2x	2.9%	€34.3m
OBS ORBIS	0.4x	4.6%	€56.3m
3ITN audius	0.8x	7.6%	€62.2m
NIII niiio finance group	2.4x	n/a	€25.9m
9L7 TPXimpact Holdings	0.4x	7.0%	€31.1m

Price-To-Sales vs Peers: 9L7 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1x).

Price to Earnings Ratio vs Industry

How does 9L7's PE Ratio compare vs other companies in the DE IT Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	15.7%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	15.7%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 9L7 is good value based on its Price-To-Sales Ratio (0.4x) compared to the German IT industry average (0.7x).

Price to Sales Ratio vs Fair Ratio

What is 9L7's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9L7 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.4x
Fair PS Ratio	0.6x

Price-To-Sales vs Fair Ratio: 9L7 is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 9L7 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€0.36	€0.96 +165.6%	11.1%	€1.07	€0.85	n/a	2
Oct ’25	€0.37	€0.96 +162.7%	11.1%	€1.07	€0.85	n/a	2
Sep ’25	€0.46	€0.96 +107.3%	11.1%	€1.06	€0.85	n/a	2
Aug ’25	€0.56	€0.96 +71.0%	11.1%	€1.06	€0.85	n/a	2
Jul ’25	€0.47	€0.89 +88.2%	19.2%	€1.06	€0.72	n/a	2
Jun ’25	€0.46	€0.89 +92.1%	19.2%	€1.06	€0.72	n/a	2
May ’25	€0.33	€0.89 +166.6%	19.2%	€1.05	€0.72	n/a	2
Apr ’25	€0.38	€0.89 +132.9%	19.2%	€1.05	€0.72	n/a	2
Mar ’25	€0.39	€0.89 +126.9%	19.2%	€1.05	€0.72	n/a	2
Feb ’25	€0.41	€0.87 +111.0%	19.2%	€1.04	€0.71	n/a	2
Jan ’25	€0.41	€0.87 +112.0%	19.2%	€1.04	€0.71	n/a	2
Dec ’24	€0.41	€0.87 +112.0%	19.2%	€1.04	€0.71	n/a	2
Nov ’24	€0.40	€0.87 +119.4%	19.2%	€1.04	€0.71	€0.36	2
Oct ’24	€0.43	€0.87 +102.5%	19.2%	€1.04	€0.71	€0.37	2
Sep ’24	€0.39	€0.87 +121.9%	19.2%	€1.03	€0.70	€0.46	2
Aug ’24	€0.40	€0.87 +116.4%	19.2%	€1.03	€0.70	€0.56	2
Jul ’24	€0.39	€0.87 +121.9%	19.2%	€1.03	€0.70	€0.47	2
Jun ’24	€0.41	€0.87 +109.1%	19.2%	€1.03	€0.70	€0.46	2
Jan ’24	€0.60	€1.01 +66.4%	41.4%	€1.42	€0.59	€0.41	2
Dec ’23	€0.56	€1.01 +81.4%	41.4%	€1.42	€0.59	€0.41	2
Nov ’23	€0.42	€1.37 +228.7%	10.0%	€1.50	€1.23	€0.40	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.